Classer les publications sur l'année
-
Biométrie et Analyses de bases de données
Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database
TAHA M.-K , WEIL-OLIVIER C , BOUEE S, EMERY C , NACHBAUR G, PRIBIL C, LONCLE-PROVOT V.
HUMAN VACCINES & IMMUNOTHERAPEUTICS ; 2021;17(6):1858-1866
-
Biométrie et Analyses de bases de données
Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance Database
WEIL-OLIVIER C, TAHA M-K, EMERY C, BOUEE S, BECK E, ARIS E, LONCLE-PROVOT V, NACHBAUR G, PRIBIL C.
Infectious Diseases and Therapy ; 2021;10(3):1607-1623
-
Pharmaco-Epidémiologie
Toxigenic Clostridium difficile carriage in general practice: results of a laboratory-based cohort study
BARBUT F, DAY N, BOUÉE S, YOUSSOUF A, GRANDVOINNET L, LALANDE V, COUTURIER J, ECKERT C
Clin Microbiol Infect ; 2019;25(5):588-594
-
Biométrie et Analyses de bases de données
Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database
TAHA M.-K , WEIL-OLIVIER C , BOUEE S, EMERY C , NACHBAUR G, PRIBIL C, LONCLE-PROVOT V.
HUMAN VACCINES & IMMUNOTHERAPEUTICS ; 2021;17(6):1858-1866
-
Biométrie et Analyses de bases de données
Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France
POURCHER V, GOURMELEN J, BUREAU I, BOUEE S
PLOS ONE ; 2020;15(12),e0243529
-
Pharmaco-Epidémiologie
Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study
DINH A, LE MONNIER A, EMERY C, ALAMI S, TORRETON É, DUBURCQ A, BARBIER F.
Eur J Clin Microbiol Infect Dis ; 2019;38(7):1297-1305
-
Pharmaco-Epidémiologie
Estimation de l’incidence des infections à papillomavirus en France
DETOURNAY B, GRANADOS-CANAL D, EL HASNAOUI A
Gynécol Obstét Fertil ; 37:125-130
-
Pharmaco-Epidémiologie
Impact sur la fonction rénale d’un relais précoce de la formulation conventionnelle de l’amphotéricine B par sa formulation liposomale dans le cadre d’un traitement empirique antifongique (Etude Nephemat)
ISNARD F, TILLEUL P, LAPORTE JF, CHEVALLIER P, PIGNEUX A, LAFUMA A, MONCHECOURT F, MAHI L, DERAY G
Med Mal Infect ; 38(4):208-214
-
Pharmaco-Epidémiologie
Cutaneous Infrared Thermometry for Detecting Febrile Patients
HAUSFATER P, ZHAO Y, DEFRENNE S, BONNET P, RIOU B
Emerg Infect Dis ; 14(8):1255-1258
-
Économie de la santé
Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France
STANDAERT B, PAREZ N, TEHARD B, COLIN X, DETOURNAY B
Appl Health Econ Health Policy ; 6(4):199-216
-
Pharmaco-Epidémiologie
A benefit for renal function after early switch to liposomal amphotericin B from conventional formulation in empirical antifungal treatment
ISNARD F, TILLEUL P, LAPORTE JF, CHEVALLIER P, PIGNEUX A, LAFUMA A, MAHI L, DERAY G
Nephrol Dial Transplant ; 22(10):3090-3091
-
Pharmaco-Epidémiologie
Stratégie diagnostique de l’infection par le VHC en médecine générale : Etats des lieux, nature des obstacles rencontrés – Etude GYMKHANA 1 (2ème partie)
AUBERT JP, BOUEE S, BENTATA M, COMPAGNON M, ELGHOZI B, LIVROZET JM, MECHALI D, PERDRIEAU F, PY AM, ROZEMBAUM W, TAULERA O, WAJSBROT A
Rev Prat - Médecine Générale ; 20(726/727):386-391
-
Pharmaco-Epidémiologie
Seroprevalence of Varicella in the French Population
KHOSHNOOD B, DEBRUYNE M, LANCON F, EMERY C, FAGNANI F, DURAND I, FLORET D
Pediatr Infect Dis J ; 25(1):41-44
-
Pharmaco-Epidémiologie
Human papillomavirus testing with a liquid-based system : feasibility and comparison with reference diagnoses
BERGERON C, CAS F, FAGNANI F, DIDAILLER-LAMBERT F, POVEDA JD
Acta Cytol ; 50(1):16-22
-
Pharmaco-Epidémiologie
ENVOL study on the medical management of varicella and its complications in French ambulatory care
EMERY C, LANCON F, FAGNANI F, PECHEVIS M, DURAND I, FLORET D
Med Mal Infect ; 36(2):92-98
Inscription à la 